&nbsp;

Drugs Used:

capivasertib,

fulvestrant

Quick Link(s):

Regimen Monograph

Oct 2025

Regimen

CAPE(RT)

Cancer Type:

Gastrointestinal,

Rectal

Intent: Neoadjuvant

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

capecitabine

Quick Link(s):

Regimen Monograph

Feb 2026

Regimen

TMZL

Cancer Type:

Central Nervous System

Intent: Adjuvant

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

BORTDEXALENA+DARA; LENA+DARA(MNT)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant

ODB - General Benefit

dexamethasone

Drugs Used:

daratumumab (Unfunded),

bortezomib (Unfunded),

lenalidomide (Unfunded),

Quick Link(s):

Regimen Monograph

Updated

Mar 2026

Regimen

BORTDEXALENA+DARA(SC); LENA+DARA(MNT-SC)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant

ODB - General Benefit

dexamethasone

Drugs Used:

daratumumab (subcut) (Unfunded),

bortezomib (Unfunded),

lenalidomide (Unfunded),

Quick Link(s):

Regimen Monograph

Updated

Mar 2026

Regimen

CAPE

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

capecitabine

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jul 2024

Regimen

CABAPRED

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

New Drug Funding Program

Cabazitaxel - Metastatic Castration Resistant Prostate Cancer

ODB - General Benefit

prednisone

Drugs Used:

cabazitaxel,

prednisone

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

MELPPRED

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

melphalan - oral tablets

ODB - General Benefit

prednisone

Drugs Used:

melphalan,

prednisone

Quick Link(s):

Regimen Monograph

Jun 2019

Regimen

CRBPETOP(PO)

Cancer Type:

Lung,

Small Cell

Intent: Adjuvant, Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

Drugs Used:

CARBOplatin,

etoposide

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CARFCYCLDEXA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

carfilzomib (Unfunded),

cyclophosphamide,

Quick Link(s):

Regimen Monograph

Oct 2023

Regimen

BORTDEXALENA(LD)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - In Combination with Lenalidomide and Dexamethasone for Previously Untreated Multiple Myeloma Without Intent for Stem Cell Transplantation

ODB Limited Use

lenalidomide - For the treatment of patients with multiple myeloma, who are deemed to be lenalidomide sensitive, and/or have not experienced progression while on a lenalidomide-based regimen in the treatment or maintenance setting, according to clinical criteria

ODB - General Benefit

dexamethasone

Drugs Used:

bortezomib (PDRP prior authorization),

lenalidomide,